Virtual Pharmacy Trade Show

USP Non-Sterile Resources, Compliance, Technology

Leading Providers of Compounding Chemicals, Compounding Supplies, Pharmacist Training, Compound Formulas, Compounding Software, & Technology...

Aisle OVERVIEW

Non-sterile pharmacy compounding refers to the process of preparing customized medications in a pharmacy setting under conditions that do not require a sterile environment. This practice involves mixing, combining, altering, or assembling pharmaceutical ingredients to meet the specific needs of an individual patient when commercially available medications are not suitable. The primary focus of non-sterile compounding is to ensure that the compounded medication is safe, effective, and tailored to the patient’s requirements while adhering to established quality control practices.

Exhibitor BOOTHS

Alliance for Pharmacy Compounding

Request information from Alliance for Pharmacy Compounding

Subscribe

The Voice for Pharmacy Compounding

APC represents compounding pharmacists and technicians in both 503A and 503B settings, as well as prescribers, educators, patients, and suppliers.

Our passion for compounding is fueled by our members’ passion for their patients — and the medications they create. APC is focused on strategies to assure that millions of patients can continue to access those compounded medications.

Our commitment — not only to our dues-paying members but also to their patients — is to lead, to influence, to speak, and to serve so that the practice of pharmacy compounding is not merely preserved but is elevated as a key component of health care delivery for millions of patients across America.

APC members subscribe to the Pharmacy Compounders Code of Ethics, comprised of 10 tenets that guide their professional, clinical, and business practices.

APC members play a vital role in the American healthcare system and in individual patients’ lives, preparing essential personalized medications for a range of issues, including autism, oncology, dermatology, ophthalmology, pediatrics, women’s health, and more.

Through its ally grassroots organization, the Partnership for Personalized Prescriptions, APC represents more than 150,000 patients, compounding professionals, prescribers, and others.

APC is committed to ensuring the rights of physicians to prescribe, of pharmacists to prepare, and of patients to take personalized medication solutions to meet their unique health care needs.

Health Care Logistics

Request information from Health Care Logistics

Subscribe

Pharmacy Compounding Supplies
The HCL Compounding and Dispensing line features a diverse selection of products with a special focus on USP 797 & 795 supplies as well as those specially designed for precise medication measuring, mixing and filling. We’re committed to offering products that help you increase productivity, maximize efficiency and improve accuracy in all aspects of your business.

To eliminate hand fatigue when packaging liquid compounds, try our Liquid Unit Dose (LUD) Press. It has an aluminum base and rod that easily seals caps onto vials or cups. Choose a heavy-duty Holder for Vials or a Holder for Cups, each of which will hold up to eight items side by side to prevent spills. A raised notch on the LUD Press platform helps guide your holder into position to create a secure seal on every vial or cup, every time. You spend less time on alignment and improve productivity.

We create metal products to match your unique specifications so you can work more efficiently and produce better results. Could your facility benefit from stainless steel storage containers, lock boxes and utility trays to simplify USP <797> compliance? Do you have an existing product you’d like to upgrade with a specially sized metal adaptor such as a bracket, plate, clamp or hanger that is USP <797> friendly? Whatever solution you seek, HCL can deliver. Our designers use stainless steel and aluminum, dependent upon your needs, and our design consultation services are always FREE!

IJPC

Request information from IJPC

Subscribe

The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly, scientific and professional digital journal emphasizing quality pharmaceutical compounding. IJPC is the only publication that covers pharmaceutical compounding topics relevant and necessary to empower pharmacists to meet the needs of today’s patients. No other publication features hands-on, how-to compounding techniques or the information that contemporary pharmacists need to provide individualized care.

Each issue includes peer-reviewed scientific articles, articles on pertinent topics, informational and professional articles, calculations, and other departments relevant to the practice of compounding. Articles and manuscripts are reviewed by pharmacy practitioners, academicians and scientists, as well as by others with expertise in various specialties.

The International Journal of Pharmaceutical Compounding is indexed by the International Pharmaceutical Abstracts,the Cumulative Index to Nursing & Allied Health Literature print index and database, the Chemical Abstracts Service, Elsevier Bibliographic Databases including EMBASE, EMNursing, Compendex, GEOBASE, Mosby Yearbooks and Scopus, the world’s largest abstract and indexing database of scientific and social sciences literature with more than 8 million users at more than 500 institutions worldwide.

Manuscripts published in the International Journal of Pharmaceutical Compounding are read and researched worldwide.

IJPC has been recognized with the following awards:

  • Houston International Association of Business
  • Communicators Award of Merit in Magazine Design
  • Houston Society for Technical Communication Distinguished Award for Technical Publications, Art & Online Competition
  • International Society for Technical Communication Excellence Award for Technical Publications, Art & Online Competition

Please contact us by phone at 800-757-4572 or click on the link below to visit our website.

Informa Connect

Request information from Informa Connect

Subscribe

Evaluate Key Areas of Compliance for Inspection Readiness, Navigate Regulatory Complexities and Discover Innovative Technologies and Solutions

The annual Compounding Pharmacy Compliance conference provides an in-depth look into key areas for compliance and proven strategies to strengthen compounding systems to ensure inspection readiness. As 2023 brought changes to USP regulations relevant to compounding, we hope you will find value in learning what these changes mean for compounding and inspections. These changes are meant to improve the quality of drugs for patients, and ensure safer conditions for compounders. Change often comes with challenges, and this event aims to help overcome the challenges and implement these changes seamlessly. A must-attend for all compounding professionals.

Key program features this year include 2 days of live content from 30+ industry thought leaders, live speaker Q&A, breakout discussions and on-demand content. Including perspectives from the US Pharmacopeia, FDA, Alliance for Pharmacy Compounding, Arizona State Board of Pharmacy, Wells Pharmacy Network, QuVa Pharma, Empower Pharmacy, Vios Compounding, Town & Country Compounding, Innovative Compounding Pharmacy, MedisourceRx, and more, this event is not to be missed.

Discuss Critical Topics Affecting the Ever-Evolving Drug Compounding Landscape:

  • Relevant insight on the regulatory implications of recent USP Chapter revisions, particularly USP 797
  • Tips on inspections and navigating FDA visits
  • And more!

PLUS! Customize Your Learning Specific to Your Needs with Tracked Programming (Choose from A or B):

A. 503A Track

  1. a. In-Depth Breakdown of Non-Sterile and Non-Hazardous Compounding Regulations
  2. b. Navigating Drug Shortages, 503b Disruptions, and Vendor Qualifications
  3. c. 503a Lab Testing, Quality Assurance and Risk Mitigation
  4. d. Hospital Compounding: Challenges in Implementing USP 800 and NIOSH List

B. 503B Track

  1. a. Navigating Drug Shortages and Challenges in Current Supply Chair
  2. b. Comprehensive Insights into 503b Quality Control
  3. c. Deep Dive on Regulatory Expectations for the Maturing 503b Industry
  4. d. Implementation of a Recombinant Factor C Technology for Endotoxin Testing at a 503b Compounding Facility

C. And more!

For more details and to register you and your team, visit https://informaconnect.com/compounding-pharmacy-compliance/.

Product Highlight SHOWCASE

The Latest Market BUZZ

Market Buzz Testing Post

Product Awareness

dev_support |

March 12, 2025

Test

Uncategorized

dev_support |

March 11, 2025

Setting Your Compliance Goals for 2025: A New Year, A New Standard

Product Awareness

Rob Arel |

February 7, 2025

[CE Webinar] USP Chapter 795 Unlocked: Keys to compliance in nonsterile compounding

Product Awareness

RXinsider Staff |

August 10, 2024

ISO Regulations and MediZap Protocols

Product Awareness

RXinsider Staff |

August 10, 2024

Make up to 225 Suppositories per batch! The new Pebble Beach Mold makes it easy to compound and yields more. Reusable. Dishwasher Safe. Food Grade Silicone.

Product Awareness

RXinsider Staff |

August 10, 2024

Subject Matter Expert & Thought Leader PROFILES

Alliance for Pharmacy Compounding

The Voice for Pharmacy Compounding

APC represents compounding pharmacists and technicians in both 503A and 503B settings, as well as prescribers, educators, patients, and suppliers.

Our passion for compounding is fueled by our members’ passion for their patients — and the medications they create. APC is focused on strategies to assure that millions of patients can continue to access those compounded medications.

Our commitment — not only to our dues-paying members but also to their patients — is to lead, to influence, to speak, and to serve so that the practice of pharmacy compounding is not merely preserved but is elevated as a key component of health care delivery for millions of patients across America.

APC members subscribe to the Pharmacy Compounders Code of Ethics, comprised of 10 tenets that guide their professional, clinical, and business practices.

APC members play a vital role in the American healthcare system and in individual patients’ lives, preparing essential personalized medications for a range of issues, including autism, oncology, dermatology, ophthalmology, pediatrics, women’s health, and more.

Through its ally grassroots organization, the Partnership for Personalized Prescriptions, APC represents more than 150,000 patients, compounding professionals, prescribers, and others.

APC is committed to ensuring the rights of physicians to prescribe, of pharmacists to prepare, and of patients to take personalized medication solutions to meet their unique health care needs.

Health Care Logistics

Pharmacy Compounding Supplies
The HCL Compounding and Dispensing line features a diverse selection of products with a special focus on USP 797 & 795 supplies as well as those specially designed for precise medication measuring, mixing and filling. We’re committed to offering products that help you increase productivity, maximize efficiency and improve accuracy in all aspects of your business.

To eliminate hand fatigue when packaging liquid compounds, try our Liquid Unit Dose (LUD) Press. It has an aluminum base and rod that easily seals caps onto vials or cups. Choose a heavy-duty Holder for Vials or a Holder for Cups, each of which will hold up to eight items side by side to prevent spills. A raised notch on the LUD Press platform helps guide your holder into position to create a secure seal on every vial or cup, every time. You spend less time on alignment and improve productivity.

We create metal products to match your unique specifications so you can work more efficiently and produce better results. Could your facility benefit from stainless steel storage containers, lock boxes and utility trays to simplify USP <797> compliance? Do you have an existing product you’d like to upgrade with a specially sized metal adaptor such as a bracket, plate, clamp or hanger that is USP <797> friendly? Whatever solution you seek, HCL can deliver. Our designers use stainless steel and aluminum, dependent upon your needs, and our design consultation services are always FREE!

IJPC

The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly, scientific and professional digital journal emphasizing quality pharmaceutical compounding. IJPC is the only publication that covers pharmaceutical compounding topics relevant and necessary to empower pharmacists to meet the needs of today’s patients. No other publication features hands-on, how-to compounding techniques or the information that contemporary pharmacists need to provide individualized care.

Each issue includes peer-reviewed scientific articles, articles on pertinent topics, informational and professional articles, calculations, and other departments relevant to the practice of compounding. Articles and manuscripts are reviewed by pharmacy practitioners, academicians and scientists, as well as by others with expertise in various specialties.

The International Journal of Pharmaceutical Compounding is indexed by the International Pharmaceutical Abstracts,the Cumulative Index to Nursing & Allied Health Literature print index and database, the Chemical Abstracts Service, Elsevier Bibliographic Databases including EMBASE, EMNursing, Compendex, GEOBASE, Mosby Yearbooks and Scopus, the world’s largest abstract and indexing database of scientific and social sciences literature with more than 8 million users at more than 500 institutions worldwide.

Manuscripts published in the International Journal of Pharmaceutical Compounding are read and researched worldwide.

IJPC has been recognized with the following awards:

  • Houston International Association of Business
  • Communicators Award of Merit in Magazine Design
  • Houston Society for Technical Communication Distinguished Award for Technical Publications, Art & Online Competition
  • International Society for Technical Communication Excellence Award for Technical Publications, Art & Online Competition

Please contact us by phone at 800-757-4572 or click on the link below to visit our website.

Informa Connect

Evaluate Key Areas of Compliance for Inspection Readiness, Navigate Regulatory Complexities and Discover Innovative Technologies and Solutions

The annual Compounding Pharmacy Compliance conference provides an in-depth look into key areas for compliance and proven strategies to strengthen compounding systems to ensure inspection readiness. As 2023 brought changes to USP regulations relevant to compounding, we hope you will find value in learning what these changes mean for compounding and inspections. These changes are meant to improve the quality of drugs for patients, and ensure safer conditions for compounders. Change often comes with challenges, and this event aims to help overcome the challenges and implement these changes seamlessly. A must-attend for all compounding professionals.

Key program features this year include 2 days of live content from 30+ industry thought leaders, live speaker Q&A, breakout discussions and on-demand content. Including perspectives from the US Pharmacopeia, FDA, Alliance for Pharmacy Compounding, Arizona State Board of Pharmacy, Wells Pharmacy Network, QuVa Pharma, Empower Pharmacy, Vios Compounding, Town & Country Compounding, Innovative Compounding Pharmacy, MedisourceRx, and more, this event is not to be missed.

Discuss Critical Topics Affecting the Ever-Evolving Drug Compounding Landscape:

  • Relevant insight on the regulatory implications of recent USP Chapter revisions, particularly USP 797
  • Tips on inspections and navigating FDA visits
  • And more!

PLUS! Customize Your Learning Specific to Your Needs with Tracked Programming (Choose from A or B):

A. 503A Track

  1. a. In-Depth Breakdown of Non-Sterile and Non-Hazardous Compounding Regulations
  2. b. Navigating Drug Shortages, 503b Disruptions, and Vendor Qualifications
  3. c. 503a Lab Testing, Quality Assurance and Risk Mitigation
  4. d. Hospital Compounding: Challenges in Implementing USP 800 and NIOSH List

B. 503B Track

  1. a. Navigating Drug Shortages and Challenges in Current Supply Chair
  2. b. Comprehensive Insights into 503b Quality Control
  3. c. Deep Dive on Regulatory Expectations for the Maturing 503b Industry
  4. d. Implementation of a Recombinant Factor C Technology for Endotoxin Testing at a 503b Compounding Facility

C. And more!

For more details and to register you and your team, visit https://informaconnect.com/compounding-pharmacy-compliance/.

Resources & Awareness

Title name, title name title, name details for title name, title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI. and remains a minority shareholder in CORE Higher Education Group.

Title name, title name title, name details for title name, title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI

Remains a minority shareholder in CORE Higher Education Group.

Title name, title name title, name details for title name, title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group.

Title name, title name title, name details for title name, title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI. and remains a minority shareholder in CORE Higher Education Group.

Title name, title name title, name details for title name, title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI. and remains a minority shareholder in CORE Higher Education Group.

Title name, title name title, name details for title name, title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group.

Title name, title name title, name details for title name, title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI. 

Title name, title name title, name details for title name, title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI. and remains a shareholder

Title name, title name title, name details for title name, title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI. and remains a minority shareholder in CORE Higher Education Group.

Title name, title name title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group.

Title name, title name title, name details for title name, title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI. and remains a minority shareholder in CORE Higher Education Group.

Title name, title name title, name details

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI. and remains a minority shareholder in CORE Higher Education Group.

Title name, title name title, name details for title name, title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI. and remains a minority shareholder in CORE Higher Education Group.

Title name, title name title, name details for title

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI. and remains a minority shareholder in CORE Higher Education Group.

Title name, title name

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI. and remains a minority shareholder in CORE Higher Education Group.

Title name, title name title, name details

8/1/2024

Gregory Cianfarani is the founder of both RXinsider and CORE Higher Education Group, MarCom and EdTech companies based in West Warwick, RI. and remains a minority shareholder in CORE Higher Education Group.

Request information from USP Non-Sterile Resources, Compliance, Technology

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe